Dow Down 1.07% Nasdaq Down 0.93%

Biogen Inc. (BIIB)

-NasdaqGS
305.78 Down 4.77(1.54%) Sep 29, 4:00PM EDT
|After Hours : 305.78 0.00 (0.00%) Sep 29, 6:30PM EDT
Prev Close:310.55
Open:310.17
Bid:300.00 x 200
Ask:320.00 x 100
1y Target Est:344.61
Beta:0.398444
Next Earnings Date:26-Oct-16BIIB Earnings announcement
Day's Range:304.04 - 312.47
52wk Range:223.02 - 333.65
Volume:1,133,926
Avg Vol (3m):1,728,190
Market Cap:67.00B
P/E (ttm):17.86
EPS (ttm):17.12
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BIIBDown 1.54%67.00B
PFEDown 1.97%202.11B
ABTDown 2.01%60.92B

Key Statistics

Forward P/E (1 yr):14.67
P/S (ttm):6.06
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :20.10
Quarterly EPS Est (Sep-16) :5.01
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):1.80

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Biogen Inc. discovers, develops, manufactures, and delivers therapies for the treatment of neurodegenerative diseases, hematologic conditions, and autoimmune disorders. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback